Progestogens for Prevention of Preterm Birth
Progestogens for Preventing Preterm Birth (2 of 2)
Formulations of progestogens have been approved by the U.S. Food and Drug Administration (FDA) but for indications other than prevention of preterm birth. These forms include:
- Vaginal suppositories, gels, and caps
- Oral formulations
A commercial formulation of progesterone for intramuscular injection has been approved for preterm birth prevention (17 alpha-hyddroxyprgesteron caproate). Formulations of progestogens may be supplied by compounding pharmacies.
- Likis FE, Andrews JC, Woodworth AL, et al. Effectiveness of Progestogens for Prevention of Preterm Birth. Comparative Effectiveness Review No. 74 (Prepared by the Vanderbilt Evidence-based Practice Center under Contract No. 290-2007-10065-I). Rockville, MD: Agency for Healthcare Research and Quality; September 2012. AHRQ Publication No. 12-EHC105-EF. Available at www.effectivehealthcare.ahrq.gov/pretermbirth.cfm.
Your slide tray is being processed.